NeuroSense Therapeutics (NRSN) Shares Outstanding (Diluted) (2022 - 2026)
NeuroSense Therapeutics (NRSN) posted Shares Outstanding (Diluted) of 1.27 million for Q2 2026, up 37.0% from 930,104 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Since Q4 2020, NeuroSense Therapeutics has reported Shares Outstanding (Diluted) for 19 quarters.
- Annual Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 35.8% (FY2020 to FY2025).
- In prior years, NeuroSense Therapeutics' Shares Outstanding (Diluted) was 930,104 in FY2024 (+36.4%), 682,008 in FY2023 (+18.6%), 575,226 in FY2022 (+84.3%) and 312,171 in FY2021 (+13.1%).
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 13.1% in Q4 2021 to 84.3% in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.70 Bn |
| 10 | NeuroSense Therapeutics | 3.97 Mn | -469,023.95 | - | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Jun 30, 2025 | 930,104.00 |
| Dec 31, 2024 | 930,104.00 |
| Sep 30, 2024 | 682,008.00 |
| Jun 30, 2024 | 682,008.00 |
| Mar 31, 2024 | 682,008.00 |
| Dec 31, 2023 | 682,008.00 |
| Sep 30, 2023 | 575,226.00 |
| Jun 30, 2023 | 575,226.00 |
| Mar 31, 2023 | 575,226.00 |
| Dec 31, 2022 | 575,226.00 |
API Access
NeuroSense Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();